Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
Sharh maqola

Targeted Protein Degradation via Lysosomes

Rishi R. PaudelDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United StatesDong LuDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United StatesSandipan ChowdhuryDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United StatesErika Y. MonroyDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United StatesJin WangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, United States
2022en
ABI

Annotatsiya

In the scope of targeted protein degradation (TPD), proteolysis-targeting chimeras (PROTACs), leveraging the ubiquitin-proteasome system, have been extensively studied. However, they are limited to the degradation of soluble and membrane proteins, excluding the aggregated and extracellular proteins and dysfunctional organelles. As an alternative protein degradation pathway, lysosomes serve as a feasible tool for accessing these untouched proteins and/or organelles by proteosomes. Here, we focus on reviewing the emerging lysosome-mediated TPD, such as AUTAC, ATTEC, AUTOTAC, LYTAC, and MoDE-A. Intracellular targets, such as soluble and aggregated proteins and organelles, can be degraded via the autophagy-lysosome pathway. Extracellular targets, such as membrane proteins, and secreted extracellular proteins can be degraded via the endosome-lysosome pathway. In addition, we summarize the mechanism and regulation of autophagy, available methods and assays for monitoring the autophagy process, and the recently developed chemical probes for perturbing the autophagy pathways.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba